Announcements Trials
Browse Landscape

Phase

Phase 2 35Phase 1 16Phase 1/2 5Phase 3 4Phase NA 1Phase EARLY_PHASE1 1

Status

Active not recruiting 2Recruiting 1Not yet recruiting 1

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 2Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 2Stomach Neoplasms 1Recurrence 1Lung Diseases 1Adenocarcinoma Of Esophagus 1

Interventions

Cisplatin 725Carboplatin 607Paclitaxel 578Cyclophosphamide 516Radiotherapy 511Docetaxel 475Fluorouracil 453Gemcitabine 437Doxorubicin 383Capecitabine 361Dexamethasone 327Oxaliplatin 288pembrolizumab 283Leucovorin 282Bevacizumab 275Etoposide 271Vincristine 270Rituximab 246Prednisone 222Pemetrexed 217Cytarabine 205Drug Therapy 194Trastuzumab 175Irinotecan 172Methotrexate 171Lenalidomide 137Nivolumab 135Filgrastim 135Epirubicin 129Tamoxifen 127

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × zimberelimab × Clear all
NCT06431633 2026-05-18

ARIAN

Fundación GECP

Phase 3 Recruiting
129 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Diseases

NCT05568095 2026-05-08

STAR-221

Arcus Biosciences, Inc.

Phase 3 Active not recruiting
1,040 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Stomach Neoplasms

NCT05502237 2026-01-30

STAR-121

Gilead Sciences

Phase 3 Active not recruiting
1,021 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05798819 2023-04-05

A Study of GLS-010 Plus Platinum-containing Chemotherapy±Bevacizumab as First-line Treatment for Persistent, Recurrent, or Metastatic Cervical Cancer

Guangzhou Gloria Biosciences Co., Ltd.

Phase 3 Not yet recruiting
424 enrolled

Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡